Reuters – GSK diabetes drug set ‘Eperzan’ for European approval

GlaxoSmithKline said on Friday European regulators had given the green light to its once-weekly diabetes drug albiglutide, which it is marketing as Eperzan.

Read more

Posted in Drugs